Jesse M. Gordon-Blake

Jesse M. Gordon-Blake

Auto-generated profile, based on publicly available information

Jesse M. Gordon-Blake

Department of Pharmaceutical Sciences, Research Resources Center, Department of Chemistry, and Department of Anatomy and Cell Biology, University of Illinois at Chicago, Chicago, Illinois 60612, United States

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Nitric Oxide
Verified
Journal Article
Closed access
MHMichael A. Hollas
Michael A. Hollas
MAManel Ben Aissa
Manel Ben Aissa
SLSue H. Lee
Sue H. Lee
JGJesse M. Gordon-Blake
Jesse M. Gordon-Blake
GTGregory R.J. Thatcher
Gregory R.J. Thatcher

6 February 2023 in Biochemistry
Verified
Journal Article
Closed access
KRKiira M. Ratia
Kiira M. Ratia
ZSZhengnan Shen
Zhengnan Shen
JGJesse Gordon-Blake
Jesse Gordon-Blake
HLHyun Lee
Hyun Lee
MLMegan S. Laham
Megan S. Laham
GTGregory R. J. Thatcher
Gregory R. J. Thatcher

14 December 2023 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
ZSZhengnan Shen
Zhengnan Shen
KRKiira Ratia
Kiira Ratia
IKIsabella Krider
Isabella Krider
MAMartha Ackerman-Berrier
Martha Ackerman-Berrier
CPChristopher Penton
Christopher Penton
GTGregory R. J. Thatcher
Gregory R. J. Thatcher
Depletion of nicotinamide adenine dinucleotide (NAD+) is associated with aging and disease, spurring the study of dietary supplements to replenish NAD+. The catabolism of NAD+ to nicotinamide (NAM) requires the salvage of NAM to replenish cellular NAD+, which relies on the rate-limiting enzyme nicotinamide phosphoribosyltransferase (NAMPT). Pharmacological activation of NAMPT provides an alternative to dietary supplements. Screening for activators of NAMPT identified small molecule NAMPT positive allosteric modulators (N-PAMs). N-PAMs bind to the rear channel of NAMPT increasing enzyme activity and alleviating feedback inhibition by NAM and NAD+. Synthesis of over 70 N-PAMs provided an excellent correlation between rear channel binding affinity and potency for enzyme activation, confirming the mechanism of allosteric activation via binding to the rear channel. The mechanism accounts for higher binding affinity leading to loss of efficacy. Enzyme activation translated directly to elevation of NAD+ measured in cells. Optimization led to an orally bioavailable N-PAM.

24 January 2024 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Open access
JGJesse Gordon-Blake
Jesse Gordon-Blake
KRKiira Ratia
Kiira Ratia
VWVictoria Weidig
Victoria Weidig
GANGA REDDY VELMAGANGA REDDY VELMA
GANGA REDDY VELMA
MAMartha Ackerman-Berrier
Martha Ackerman-Berrier
GTGregory R. J. Thatcher
Gregory R. J. Thatcher
Evidence supports boosting nicotinamide adenine dinucleotide (NAD+) to counteract oxidative stress in aging and neurodegenerative disease. One approach is to enhance the activity of nicotinamide phosphoribosyltransferase (NAMPT). Novel NAMPT positive allosteric modulators (N-PAMs) were identified. A cocrystal structure confirmed N-PAM binding to the NAMPT rear channel. Early hit-to-lead efforts led to a 1.88-fold maximum increase in the level of NAD+ in human THP-1 cells. Select N-PAMs were assessed for mitigation of reactive oxygen species (ROS) in HT-22 neuronal cells subject to inflammatory stress using tumor necrosis factor alpha (TNFα). N-PAMs that increased NAD+ more effectively in THP-1 cells attenuated TNFα-induced ROS more effectively in HT-22 cells. The most efficacious N-PAM completely attenuated ROS elevation in glutamate-stressed HT-22 cells, a model of neuronal excitotoxicity. This work demonstrates for the first time that N-PAMs are capable of mitigating elevated ROS in neurons stressed with TNFα and glutamate and provides support for further N-PAM optimization for treatment of neurodegenerative diseases.